These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 12759577

  • 1. Extracellular actin impairs glomerular capillary repair in experimental mesangioproliferative glomerulonephritis.
    Janssen U, Eitner F, Kunter U, Ostendorf T, Wolf G, Chaponnier C, Gabbiani G, Kerjaschki D, Floege J.
    Nephron Exp Nephrol; 2003; 93(4):e158-67. PubMed ID: 12759577
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.
    Masuda Y, Shimizu A, Mori T, Ishiwata T, Kitamura H, Ohashi R, Ishizaki M, Asano G, Sugisaki Y, Yamanaka N.
    Am J Pathol; 2001 Aug; 159(2):599-608. PubMed ID: 11485918
    [Abstract] [Full Text] [Related]

  • 3. A novel, dual role of CCN3 in experimental glomerulonephritis: pro-angiogenic and antimesangioproliferative effects.
    van Roeyen CR, Boor P, Borkham-Kamphorst E, Rong S, Kunter U, Martin IV, Kaitovic A, Fleckenstein S, Perbal B, Trautwein C, Weiskirchen R, Ostendorf T, Floege J.
    Am J Pathol; 2012 May; 180(5):1979-90. PubMed ID: 22538190
    [Abstract] [Full Text] [Related]

  • 4. Hepatocyte growth factor-stimulating endothelial cell growth and accelerating glomerular capillary repair in experimental progressive glomerulonephritis.
    Mori T, Shimizu A, Masuda Y, Fukuda Y, Yamanaka N.
    Nephron Exp Nephrol; 2003 May; 94(2):e44-54. PubMed ID: 12845230
    [Abstract] [Full Text] [Related]

  • 5. VEGF(165) mediates glomerular endothelial repair.
    Ostendorf T, Kunter U, Eitner F, Loos A, Regele H, Kerjaschki D, Henninger DD, Janjic N, Floege J.
    J Clin Invest; 1999 Oct; 104(7):913-23. PubMed ID: 10510332
    [Abstract] [Full Text] [Related]

  • 6. Selective cyclooxygenase-2 inhibition impairs glomerular capillary healing in experimental glomerulonephritis.
    Kitahara M, Eitner F, Ostendorf T, Kunter U, Janssen U, Westenfeld R, Matsui K, Kerjaschki D, Floege J.
    J Am Soc Nephrol; 2002 May; 13(5):1261-1270. PubMed ID: 11961014
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of capillary repair in proliferative glomerulonephritis results in persistent glomerular inflammation with glomerular sclerosis.
    Masuda Y, Shimizu A, Kataoka M, Arai T, Ishikawa A, Du X, Saito SK, Aki K, Nagasaka S, Mii A, Fujita E, Fukuda Y.
    Lab Invest; 2010 Oct; 90(10):1468-81. PubMed ID: 20644521
    [Abstract] [Full Text] [Related]

  • 8. Recovery of damaged glomerular capillary network with endothelial cell apoptosis in experimental proliferative glomerulonephritis.
    Shimizu A, Masuda Y, Kitamura H, Ishizaki M, Sugisaki Y, Yamanaka N.
    Nephron; 1998 Oct; 79(2):206-14. PubMed ID: 9647502
    [Abstract] [Full Text] [Related]

  • 9. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
    Rost S, Daniel C, Schulze-Lohoff E, Bäumert HG, Lambrecht G, Hugo C.
    Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
    [Abstract] [Full Text] [Related]

  • 10. Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safety.
    Burg M, Ostendorf T, Mooney A, Koch KM, Floege J.
    Lab Invest; 1997 Apr; 76(4):505-16. PubMed ID: 9111513
    [Abstract] [Full Text] [Related]

  • 11. Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo.
    Hugo CP, Pichler RP, Schulze-Lohoff E, Pröls F, Adler S, Krutsch HC, Murphy-Ullrich JE, Couser WG, Roberts DD, Johnson RJ.
    Kidney Int; 1999 Jun; 55(6):2236-49. PubMed ID: 10354272
    [Abstract] [Full Text] [Related]

  • 12. C-type natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo.
    Canaan-Kühl S, Ostendorf T, Zander K, Koch KM, Floege J.
    Kidney Int; 1998 May; 53(5):1143-51. PubMed ID: 9573528
    [Abstract] [Full Text] [Related]

  • 13. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
    Chen YM, Chien CT, Hu-Tsai MI, Wu KD, Tsai CC, Wu MS, Tsai TJ.
    Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
    [Abstract] [Full Text] [Related]

  • 14. Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis.
    Iruela-Arispe L, Gordon K, Hugo C, Duijvestijn AM, Claffey KP, Reilly M, Couser WG, Alpers CE, Johnson RJ.
    Am J Pathol; 1995 Dec; 147(6):1715-27. PubMed ID: 7495296
    [Abstract] [Full Text] [Related]

  • 15. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
    Yoshimura A, Nemoto T, Sugenoya Y, Inui K, Watanabe S, Inoue Y, Sharif S, Yokota N, Uda S, Morita H, Ideura T.
    Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745
    [Abstract] [Full Text] [Related]

  • 16. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
    Tesch GH, Lan HY, Atkins RC, Nikolic-Paterson DJ.
    Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis.
    Floege J, Eng E, Young BA, Couser WG, Johnson RJ.
    Kidney Int; 1993 Feb; 43(2):369-80. PubMed ID: 8441232
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.